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Abstract
Carbapenem-resistant Gram-negative organisms are increasingly isolated from lower respi-
ratory tract infections. Limited treatment options are the main problems for physicians and 
clinical microbiologists who have to face such clinical cases. Bacteriological diagnosis, start-
ing with accurate Gram smear performed from properly collected specimens and ending 
with antibiotic susceptibility testing, is essential. Morphological characters of bacterial cells 
provide important clues about the nature of infection, prior to bacterial isolation and iden-
tification. Attempts to find complementary options for the respiratory contamination and 
treatment of carbapenem-resistant Gram-negative bacillary pneumonia led us to test the sus-
ceptibility of 21 essential oils. Among them, Thymus vulgaris, Eugenia caryophyllata, Origanum 
vulgare, Melaleuca alternifolia and Aniba rosaeodora essential oils proved to be efficient against 
Acinetobacter baumannii carbapenem-resistant strain and Escherichia coli ATCC 25922. In an 
attempt to evaluate the magnitude of environmental spreading of the carbapenemase genes, 
40 carbapenemase sequences of different organisms were compared. Carbapenemases show 
striking similarities inside each beta-lactamase class (A, D, and B), no matter their origin—
environmental organisms or clinical isolates. Class B carbapenemases are most widely dis-
tributed, metallo-beta-lactamases being present in bacteria as well in Archaea.
Keywords: carbapenemase producer, nosocomial pneumonia, essential oils, 
environmental pollution
1. Introduction
Enterobacteriaceae and nonfermenters Gram-negative bacilli are increasingly isolated from 
lower respiratory tract infections. In patients in intensive care units (ICUs), the ventilator-
associated pneumonia (VAP) is a constant concern for practitioners [1]. Improving the 
management of bacterial pneumonia led to guidelines for use by health-care personnel. 
© 2018 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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distribution, and reproduction in any medium, provided the original work is properly cited.
Nosocomial infections caused by Gram-negative bacteria resistant to carbapenems, mostly 
multiple-resistant, represent a challenge due to limited treatment options [2, 3]. Like other 
beta-lactamines, the carbapenems are included in preferred treatment regimens for various 
infectious diseases [4]. Antibiotic-resistant patterns of bacterial isolates from nosocomial 
infections are continuously changed. Therefore, it is of highest interest in finding alternative 
methods for preventing contamination with multidrug-resistant strains. Since ancient times, 
people have had an intuitive feeling that some spices have real benefits not only as air fresh-
eners but also in that era they were the only therapeutic option for many diseases. Thus, they 
correctly guessed that concentrated lotions/oils are not only more efficient but easy to use and 
to store. Essential oils (EOs) from natural products proved their positive effects in various clin-
ical conditions. Although the specific mechanisms of their components are not deciphered, 
many studies demonstrated certain biological activity of some phytochemicals. Terpinen-4-ol 
found in many EOs are demonstrated to act synergistically with chemotherapeutic agents in 
digestive malignancies [5]. There are many studies about antibacterial effects of EOs, mainly 
on supragingival plaque. The results are not constant, for example, some authors do not find 
a positive effect of tea tree oil on supragingival plaque [6].
Antibiotic-resistance genes are nowadays a constant presence not only in the hospital envi-
ronment but are also more and more demonstrated in various ecosystems [7–9]. Antibiotic-
resistance genes naturally already exist in organisms living in most diverse environments. 
Surely, antibiotic-resistance genes have an essential role in maintaining of inter-species equilib-
rium on specific ecosystems [10]. All living things from prokaryotes to eukaryotes are constantly 
exposed to a huge mixture of organic and inorganic compounds. Even if, nowadays, accurate 
methods exist to isolate and to characterize antibiotic-resistant microorganisms, it is not possible 
to calculate the influence of a myriad factors that interfere in every environment. An interesting 
study demonstrated the utility of transmission electron microscopy for observing of aquatic 
microorganism structural abnormalities in different environmental conditions [11]. The terres-
trial ecosystem is also prone to be reshaped by human activities [12]. Intensive farming implies 
antibiotics, so the spread of intestinal bacteria which harbor antibiotic-resistance genes is an 
immediate consequence. This does not imply that once a certain bacteria species is present in a 
certain geographic area its antibiotic-resistance pattern remains unchanged. Atmospheric condi-
tions, notably rainfalls, could contribute to spreading of contaminants from the soil to ground-
water and greatly alter the count of microorganisms. Different bacterial species do not behave 
the same, antibiotic-resistance patterns differently changed, but certain beta-lactamines could be 
used as indicators of antibiotic resistance at least for Escherichia coli [13]. Consequently, it is not 
wrong to include antibiotic-resistance genes into the long list of environmental pollutants [14].
The physicians require bacteriological diagnosis on admission of the patients in ICUs and 
for surveillance of any nosocomial infection. For respiratory infections, Gram smears from 
sputum, endotracheal aspirate, or bronchoalveolar lavage are mandatory. Very often in ICUs, 
respiratory infections are due to carbapenem-resistant Gram-negative bacilli. In our opinion, 
testing volatile EOs, as complementary substances, for prevention of respiratory infections is 
not a futile idea. Finally, last but not least, wide use of antibiotics alters not only the hospital 
environment but also disturbs other ecological niches (water and soil). These topics will be 
our concern in the next sections.
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2. Carbapenem resistance
The carbapenems are sometimes the last-resort antibiotics for treating of extended spec-
trum beta-lactamase (ESBL) producing Gram-negative bacteria. But carbapenem resis-
tance is increasingly reported in Enterobacteriaceae and nonfermenters like Acinetobacter 
spp. or Pseudomonadaceae. Carbapenem resistance is mainly due to carbapenemase (E.C. 
3.5.2.6) production. Structural classification of beta-lactamases implies the primary struc-
ture (sequence homology) and distinguishes four molecular classes of beta-lactamases—
A, C, D (serine beta-lactamases), and B (MBL-metallo beta-lactamase) [15–17]. Functional 
classifications of beta-lactamases are more closer to clinical issues [18, 19] and recognize 
three groups of beta-lactamases: Group 1 (Class C) cephalosporinases; Group 2 (Classes 
A and D) broad-spectrum beta-lactamases, inhibitor-resistant beta-lactamases, extended-
spectrum beta-lactamases, serine carbapenemases, and Group 3 metallo-beta-lactamases. 
So far in this section, we have taken in consideration only different types of beta-lacta-
mases as a resistance mechanism. Besides producing carbapenemases, the reduction of 
carbapenem influx into the periplasma is commonly observed in clinical isolates. Different 
mutations in porins significantly contribute to the failing of drug accumulation at appro-
priate concentration in periplasmic space; therefore, carbapenem resistance is often more 
complex than one thought at the first sight [20]. Readers, who wish to know further details 
regarding carbapenem resistance, should consult excellent papers devoted to this particu-
lar topic [21–24].
3. Microbiological investigations
Microbiological evaluation is mandatory for an adequate therapeutic regimen; accurate iden-
tification of the bacterial species is essential to avoid administration of broad-spectrum anti-
biotics. The optimal recovery of the pathogens ultimately depends on the accuracy of sample 
collection (sputum, endotracheal aspirate, or bronchoscopically obtained specimens by bron-
choalveolar lavage). Bacteriological assessment of lower respiratory tract infections begins 
with care evaluation of Gram-stained smear performed from respiratory tract specimen. The 
low-power scanning provides a first sight of the quality of the sample—for sputum more than 
10 squamous epithelial cells show oropharyngeal contamination. The examination with the 
oil immersion provides more details regarding bacterial morphology. The importance of this 
step in the management of bacterial pneumonia is well recognized. As illustrated in Figures 1 
and 2, it is possible to anticipate the diagnosis toward a nonfermenter or an Enterobacteriaceae. 
Acinetobacters are short Gram-negative nonsporing bacilli but in exponential phase became 
coccoids often arranged in diplo. Many strains are encapsulated and sometimes retain the 
methyl violet in Gram’s stain. The Enterobacteriaceae appear typically as Gram-negative non-
sporing bacilli with parallel sides and rounded ends. There are wide ranges of derivatives 
from this classical appearance, from filamentous rods to coccoids. Some species are encapsu-
lated, for example, Klebsiella, sometimes E. coli.
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Since this chapter is not intended to be a highly elaborate description of bacterial diagnosis of 
Gram-negative bacillary pneumonia, further details about isolation and bacterial identifica-
tion were not be reviewed. However, the microscopic examination of clinical sample offers 
essential clues about the nature of bacterial infection. For busy clinicians—in ICUs the phy-
sicians have always needed a microbiologic response as quickly as possible—these details, 
provided in advance, could make the difference.
4. Therapeutic issues
4.1. Prevention of respiratory contamination
A particular issue of ventilator associated pneumonia (VAPs) is the risk of infection with 
multidrug-resistant strains and carbapenem-resistant bacilli too. Not surprisingly, severely 
Figure 1. High-power examination (1000× magnification). Gram-stained smear of endotracheal aspirate shows Gram-
negative coccobacilli isolated or in diplo (Acinetobacter spp.).
Figure 2. High-power examination (1000× magnification). Gram-stained smear of endotracheal aspirate shows Gram-
negative capsulate rods.
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injured patients—VAPs and burn patients—are most prone to infection with carbapenem-
resistant species. The chief question for carbapenem-resistant Gram-negative bacillary pneu-
monia is how to efficiently prevent them. First of all, could these infections be stopped? In the 
hospital environment, hand hygiene and alcohol-based disinfection remain, undeniably, the 
sanitation gold standard. Rigorous monitoring of patients at admission and an accurate his-
tory are early stages in identification of patients with documented multidrug-resistant strains 
for further isolation or, at least clustering separately to prevent the risk of cross-contamination 
[25, 26]. Respiratory contamination depends on so many circumstances, almost impossible to 
eliminate, that the specific strategies are designed in order to reduce VAP, rather than to elimi-
nate such infections [27]. What else could be taken in consideration apart from already estab-
lished strategies? As it was underlined in introduction, from the ancient times, people are 
aware of the so-called air purification performed intuitively by burning scented substances or 
widespread use of all sorts of perfumes, plant extracts, or spices.
4.2. Antibiotic therapy
Antibiotic regimens of carbapenem-resistant bacillary pneumonia often rely only on few anti-
biotics. Although there is not an ideal therapeutic regimen for the treatment of pneumonia 
due to carbapenem-resistant species, Polymixin B, Tigecycline, and Amikacine remain the 
most valid options [28]. A prerequisite for adequate treatment of VAPs is intravenous admin-
istration of the suitable antibiotic. Aerosolized antibiotics delivery has been experimentally 
studied in order to reduce the side effects of systemic administration of antibiotics. Efficiency 
of these methods relies on the antibiotics’ ability on crossing the alveolar-capillary membrane 
[29]. An abundant literature is devoted to the issue of carbapenem-resistant strains. Because 
antibiotic resistance continuously evolved, clinical guidelines rapidly changed, therefore, a 
unique treatment scheme is almost impossible to establish. Clearly, we must look at the infor-
mation provided by extensive epidemiological studies to up-date infection control and treat-
ment options [30].
4.3. Inhibitory activity of essential oils
In spite of specific protocols implemented in ICUs, it is worthwhile to consider additional 
methods to prevent respiratory contamination. We should be considering the inhibitory effect 
of some essential oils (EOs), underlining the efficiency of volatile substances. EOs are more 
and more regarded as complementary to antibiotic therapy [31–35]. In our previous work, we 
demonstrated the high activity of EOs against E. coli for coriander (Coriandrum sativum L.), 
peppermint (Mentha piperita L.), and juniper (Juniperus communis L.) [36].
4.3.1. Materials and methods
We are interested in evaluating of the efficiency of some EOs against carbapenem-resistant 
Acinetobacter baumannii and E. coli ATCC 25922. A. baumannii is a ubiquitous nonfermenter 
species, found in soil, water, and clinical units, and E. coli is a constant presence of the nor-
mal microbiocenosis of humans and warm-blood animals. Of hundreds of natural products 
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commercially available, without prescription, only 21 volatile extracts (Table 1) were tested 
undiluted by two methods—diffusimetric method and aromatogram—described elsewhere 
[36]. Diffusimetric sensibility testing demonstrates the antibacterial activity by charging 5 mm 
diameter sterile paper disk with 2 or 5 μl of EOs. The aromatogram method is illustrated in 
Figure 3. Each experiment was performed three times at intervals of 2–3 days. The results are 
presented as mean and standard deviation (SD).
No EO Species Family Producer Administration
1 Thyme Thymus vulgaris Lamiaceae Fares Internal use, 
aromatherapy, 
massage
2 Clove Eugenia 
cayophyllata
Myrtaceae Fares Internal use, 
aromatherapy, 
massage
3 Eucalyptus Eucalyptus 
globulus
Myrtaceae Fares Internal use, 
aromatherapy, 
massage
4 Juniper Juniperus 
communis
Cupressaceae Fares Internal use, 
aromatherapy, 
massage
5 Lavander Lavandula 
angustifolia
Lamiaceae Fares Internal use, 
aromatherapy, 
massage
6 Mint Mentha piperita Labiatae Fares Internal use, 
aromatherapy, 
massage
7 Pine Pinus silvestris Pinaceae Fares Internal use, 
aromatherapy, 
massage
8 Rosemary Rosmarinus 
officinalis
Lamiaceae Fares Internal use, 
aromatherapy, 
massage
9 Tea tree Melaleuca 
alternifolia
Myrtaceae Fares Internal use, 
aromatherapy, 
massage
10 Oregano Origanum vulgare Lamiaceae Steaua Divina Internal use, 
aromatherapy, 
massage
11 Negril Nigella sativa Ranunculaceae Steaua Divina Internal use, 
aromatherapy, 
massage
12 Lemon Citrus limonum Rutaceae Steaua Divina Internal use, 
aromatherapy, 
massage
13 Fennel Foeniculi fructus Apiaceae Hofigal Internal use
14 Sage Salvia officinalis Lamiaceae Solaris Aromatherapy, 
massage
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4.3.2. Results
4.3.2.1. Diffusimetric method
Figures 4–7 showing EOs inhibitory activity, demonstrate antibacterial activity for the two 
Gram-negative species tested. Before we comment on the implication of these results, it is 
worth considering the obvious antibacterial effect of some EOs. In particular, it is worth men-
tioning that we obtain more precise results—the smallest SDs—when 5 μl EOs are tested. 
No EO Species Family Producer Administration
15 Sandalwood Santal amyris Rutaceae Herbavit Aromatherapy, 
massage
16 Seeds of apricots Prunus armeniaca Rosaceae Herbavit Internal use
17 Incense Boswellia serrata Burseraceae Bionovativ Internal use
18 Inhalant Pinus sylvestis, Salvia officinalis, 
Chamommilla recutita, Lavandula 
angustifolia extracts, Propolis cera, 
Eucalyptus oil
Tisofit Inhalations
19 Grapefruit Citrus paradisi Rutaceae Solaris Aromatherapy, 
massage
20 Orange Citrus sinensis Rutaceae Solaris Aromatherapy, 
massage
21 Rosewood Aniba rosaeodora Lauraceae Solaris Aromatherapy, 
massage
Table 1. The characteristics of the essential oils.
Figure 3. Aromatogram. In the middle of a sterile paper disk, with diameter of a Petri dish lid, 10 μl of essential oil was 
deposed. After sealing the assembly, the volatile effect was tested.
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Figure 4. Diffusimetric method carbapenem-resistant A. baumanii tested by 2 μl EOs (see Table 1 for the coresponding 
numbers).
Figure 5. Diffusimetric method carbapenem-resistant A. baumanii tested by 5 μl EOs (see Table 1 for the coresponding 
numbers).
Figure 6. Diffusimetric method E. coli ATCC 25922 tested by 2 μl EOs (see Table 1 for the coresponding numbers).
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Thymus vulgaris, Eugenia cayophyllata, Origanum vulgare, and Aniba rosaeodora oils not only are 
by far the most effective but also obviously inhibit A. baumannii more efficiently than E. coli. 
Alternatively, Melaleuca alternifolia is slightly more effective against E. coli when diffusimet-
ric method was used. Diffusimetric method also permits observing other important details. 
Although only clear inhibition zone was measured, E. cayophyllata shows residual growing, 
which is not measured and demonstrates a very good inhibitory activity. Also, it demon-
strates an agonist effect in combination with T. vulgaris. Contrary, O. vulgare and Nigella sativa 
show an antagonistic effect.
4.3.2.2. Aromatogram
Aromatogram method (Figures 8 and 9) reveals more interesting evidence of usefulness of 
volatile effects of at least seven essential oils: T. vulgaris, E. caryophyllata, O. vulgare, A. rosaeo-
dora, Lavandula angustifolia, Mentha piperita, and M. alternifolia. Surprisingly, some EOs, like 
mint, proved to be more effective when volatile effect is tested. The susceptibility testing was 
repeated after several weeks, but the results are inconsistent, mostly for mint, which showed 
no inhibitory effect after several weeks after opening the bottle. For other EOs (thyme, clove, 
eucalyptus, oregano, and rosewood) the antibacterial effect was not changed in time. Anyway, 
using single-use vials may be an option.
Synthetic results are listed in Table 2. At first glance, we noticed a remarkable antibacterial 
activity for T. vulgaris, E. caryophyllata, O. vulgare, and A. rosaeodora. Three other EOs could 
be considered as being efficient (M. alternifolia, Lavandula angustifolia, and M. piperita), but 
ten of them proved to have no antibacterial effect at any concentration tested. Eucalyptus 
globulus and J. communis could be considered for topical use, but not for their volatile prop-
erties. Four EOs (E. globulus, Lavandula angustifolia, M. piperita, and Rosmarinus officinalis) 
show multiple resistant colonies inside inhibition zone when E. coli was tested by aromato-
gram. Therefore, we consider them without antibacterial activity when volatile effect is 
considered.
Figure 7. Diffusimetric method E. coli ATCC 25922 tested by 5 μl EOs (see Table 1 for the coresponding numbers).
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Figure 9. E. coli ATCC 25922 tested by 10 μl EOs (see Table 1 for the coresponding numbers).
Figure 8. Aromatogram carbapenem-resistant A. baumanii tested by 10 μl EOs (see Table 1 for the coresponding numbers).
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EOs Carbapenem-resistant A. baumannii E. coli ATCC 25922
2 μl 5 μl 10 μl 2 μl 5 μl 10 μl
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
1 Thyme 38.33 mm 
(10.41)
66.67 mm 
(5.77)
70.00 mm 
(5.00)
28.00 mm 
(3.61)
65.00 mm 
(8.66)
75.00 mm 
(5.00)
2 Clove 21.67 mm 
(6.51)
32.33 mm 
(2.52)
46.67 mm 
(2.89)
19.00 mm 
(5.29)
29.33 mm 
(2.31)
33.33 mm 
(7.64)
3 Eucalyptus 9.67 mm 
(2.52)
16.00 mm 
(3.61)
NI 8.00 mm 
(1.73)
16.00 mm 
(3.46)
NI
mrc
4 Juniper 16.33 mm 
(2.52)
23.00 mm 
(1.73)
NI 14.67 mm 
(4.62)
27.33 mm 
(2.52)
NI
5 Lavander 10.33 mm 
(0.58)
14.67 mm 
(2.52)
19.67 mm 
(5.51)
11.67 mm 
(0.58)
20.33 mm 
(3.51)
NI
mcr
6 Mint 13.67 mm 
(2.31)
20.67 mm 
(6.51)
39.00 mm 
(6.56)
7.00 mm 
(0.00)
15.00 mm 
(1.00)
NI
mcr
7 Pine NI NI NI NI NI NI
8 Rosemary 12.33 mm 
(±4.62)
16.33 mm 
(±1.53)
NI 10.33 mm 
(±3.51)
18.67 mm 
(±1.53)
NI
mcr
9 Tea tree 15.67 mm
(8.14)
24.67 mm 
(3.51)
26.33 mm 
(4.16)
18.33 mm 
(7.64)
23.33 mm 
(2.89)
11.00 mm 
(6.56)
10 Oregano 46.00 mm 
(±2.00)
70.00 mm 
(0.00)
77.67 mm 
(2.52)
29.67 mm 
(0.58)
40.33 mm 
(1.53)
76.00 mm 
(1.73)
11 Negril NI NI NI NI NI NI
12 Lemon NI NI NI NI NI NI
13 Fennel 6.00 mm 
(0.00)
6.33 mm 
(0.58)
NI 6.00 mm 
(0.00)
NI NI
14 Sage NI NI NI NI NI NI
15 Sandalwood NI NI NI NI NI NI
16 Seeds of 
apricots
NI NI NI NI NI NI
17 Incense NI NI NI NI NI NI
18 Inhalant NI NI NI NI NI NI
19 Grapefruit NI NI NI NI NI NI
20 Orange NI NI NI NI NI NI
21 Rosewood 16.00 mm 
(1.00)
32.33 mm 
(11.59)
80.00 mm 
(0.00)
14.67 mm 
(0.58)
30.33 mm 
(9.50)
50.00 mm 
(2.00)
NI—no inhibition; mrc—multiple resistant colonies.
Table 2. The inhibition of carbapenem-resistant A. baumannii and E. coli ATCC 25922 by 21 EOs. The results are reported 
as the mean (SD—standard deviation) of three independent experiments.
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4.4. Discussion
In this study, commercial undiluted EOs were tested. There are some differences on viscosity, 
dispersion, vaporization, and other physical properties that, no doubt, influence the antibac-
terial activity. Although no proof can be given, the presence of antibiotic-resistance genes 
does not influence the efficiency of EOs. Therefore, an intuitive feeling turned our attention to 
the utility of these products in prevention or, why not, treatment of antibiotic-resistant Gram-
negative bacillary respiratory infections. Although there are precise methods for identifying 
the chemicals with antibacterial activity, these are not important for our purpose. Note that 
here we are speaking of a screening of some commercial EOs that anyone can buy with-
out medical prescription. Some authors demonstrate discrepancy of antimicrobial activity of 
EOs from different herbal varieties [37–40]. Of course, as we observed in our study, accurate 
description of physicochemical properties are needed [41], but for clinical purpose, the overall 
activity of EOs is relevant. In our opinion, a plant product should be considered as a distinct 
entity, and we can be certain that each component is synergistic to each other in a manner that 
exceeds the individual action of separated molecules. As we are speaking of living things, 
plant properties greatly depends on geographic area of collection, weather influence, manu-
facturing protocols, preservation conditions, species variety, and so on. Because natural plant 
products are considered safe, diverse possible applications were investigated: in agriculture 
for preventing crop diseases, monitoring soil characteristics [42, 43], or as industrial preserva-
tion solutions [44].
5. Environmental source of carbapenem-resistant strains
5.1. General considerations
Extensive studies are devoted to the ecotoxicity of industrial compounds or of pharma-
ceutical wastes [45]. Even though existing tools permit measurement of the concentration 
of any chemical in a certain geographic area, it is almost impossible to accurately estimate 
the influence of external factors that, no doubt, interfere with the spread or chemical trans-
formation of any substance—like antibiotics. When biology occurs, the problems become 
more complicated. Nowadays, a different approach in follow-up to the intricate relation-
ships of abundant microorganisms from a specific environment is needed. Antibiotics, like 
any other chemicals, do not differ in the way of spreading, accumulation, and changing 
certain environmental characteristics. It is not an exaggeration to state that multidrug-
resistant microorganisms from hospital facilities are the nightmare of health practitioners. 
Analyzing bacterial species one by one provides certain information, but the big picture 
contains much more. Before starting to accumulate new data, there are huge unexplored 
resources, like public databases. Our concern was related to the magnitude of change on 
environmental microbiome by medical activities, especially the use of carbapenems. We 
extensively searched carbapenemases, or similar beta-lactamases, in protein databases 
available, and we compared their similitudes depending on their isolation source. The goal 
of searching similitudes between carbapenemase of clinical samples and their counterpart 
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of  environmental origin was to assess the influence of medical activities in changing soil and 
water microbiota.
5.2. Data collection and methods
Herein, we have focused on comparison of the carbapenemases, from different sources, 
deposited in public databases—NCBI/National Center for Biotechnology Information (https://
www.ncbi.nlm.nih.gov/protein). The preliminary results were briefly presented in the First 
Conference of the Romanian Association of Laboratory Medicine [46]. Carbapenemase sam-
pling was carried out to cover all beta-lactamase classes. In summary, 40 FASTA carbapen-
emase sequences were collected, and then a pairwise sequence alignment (EMBOSS Needle 
Program) and multiple sequence alignment (Clustal Omega tool) were performed [47–49]. 
The default settings were used. Table 3 lists the characteristics of the sequences used for fur-
ther comparisons. Sequences for Classes A, B, and D belonging to Archaea and bacteria were 
selected. Alignment sequence based on protein crystal structure was not possible due to lack 
of crystal structures available for beta-lactamases isolated from environmental samples.
5.3. Results and discussion
The major limit of the present study is the scarcity of carbapenemases of environmental 
source deposited in the public databases. Most of environmental beta-lactamases found 
belong to Classes B and D. The archaeal beta-lactamases found are metallo-hydrolase, and 
metal ions probably contribute to enzymes stability in extreme environmental conditions. 
Searching was extended to Eukaryota domain of life, but any sequences were included in the 
present study. Only two beta-lactamases-like of eukaryotic origin were retrieved—Homo sapi-
ens (NP_057111) and Caenorhabditis elegans (NP_497107). Even they show MBL-folding, their 
similarity with other class B carbapenemases are very low, being more close to one hypotheti-
cal protein from Sulfolobus acidocaldarius (WP_01538554)—20.5% identity with NP_057111; 
23.2% with NP_497107, respectively.
On the other hand, environmental Classes A, B, and D carbapenem-hydrolyzing enzymes are 
very similar with carbapenemases of clinical sources. Some carbapenemases, such as IMI-2, 
IMI-3, NDM-1, or OXA-48, are the same regardless their origin as observed by sequences 
pairwise comparison [50, 51]. For further statistical analysis, identity percent was recovered. 
Student’s t-test assuming unequal sample variance was performed. The limit of this approach 
is due to the differences in the sequences length. The Needle program calculates identity, 
similarity, and score according to number of residues. Anyway, observing the data from 
Table 4, we noticed that environmental serine beta-lactamases are more similar with their 
clinical enterobacterial counterparts than with nonfermenters carbapenemases. The most 
striking differences are observed for subgroups IMI-3 of uncultured bacteria (ALJ52278) iso-
lated from river sediment in China and OXA-48-like of uncultured bacteria (AJF40233) iso-
lated from river sediment in Portugal. For ALJ52278 (IMI-3) beta-lactamase, 73.03% identity 
mean (CI 95 ± 25.33) with Class A carbapenemases of clinical Enterobacteria was noticed. More, 
sequences pairwise comparison reveals 93.50% identity with subgroups IMI-2 (Enterobacter 
asburidae WP_032491237), IMI-2 (E. coli AEU10762), and IMI-14 (Enterobacter hormaechei 
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Class Source Organism (accession number) isolation source Beta-lactamase Residues
Archaea
MBL-fold ES Sulfolobus acidocaldarius (WP_011278945) MBL fold metallo-hydrolase 305
Sulfolobus acidocaldarius (WP_015385554) Hypothetical protein 298
Hadesarchaea archaeon (KUO42968) MBL fold metallo-hydrolase 395
Archaeoglobus fulgidus (WP_010877604) MBL fold metallo-hydrolase 293
Vulcanisaeta distributa (WP_013336995) MBL fold metallo-hydrolase 306
Bacteria
A ES Enterobacter asburiae (AIL29239)/water IMI-2 192
uncultured bacterium (ALJ52278)/river sediment, 
Haithe River, China
IMI-3 280
E Escherichia coli (WP_015059046) GES-20 287
Serratia fonticola (4EV4) SFC-1 E166A mutant 283
Serratia marcescens (1DY6) SME-1 267
Enterobacter asburiae (WP_032491237) IMI-2 292
Escherichia coli (AEU10762) IMI-2 292
Enterobacter hormaechei (APY16311) IMI-14 292
N Pseudomonas aeruginosa (WP_021018677) KPC 293
Pseudomonas aeruginosa (4GNU) GES-5 287
Acinetobacter baumannii (3TSG) GES-14 287
B ES Serratia sp. Sr_CGKV333_2014 (ALL98459)/
poultry flock soil, India
NDM_FIM-like_MBL-B1 270
Acinetobacter junii (YP_009062718)/livestock farms, 
China
NDM-1 (plasmid) 270
Acinetobacter calcoaceticus (YP_009060354)/
livestock farms, China
NDM-1 (plasmid) 270
E Klebsiella pneumoniae (4UWS) VIM-26 266
Klebsiella pneumoniae (5A87) VIM-5 248
Klebsiella pneumoniae (3SPU) NMD-1 265
N Pseudomonas aeruginosa (4NQ2) VIM-2 261
Pseudomonas aeruginosa (AAR15341) SPM-1 276
Pseudomonas aeruginosa (ALU10771) NMD-1 270
Pseudomonas aeruginosa (AGH20684) IMP-15 246
Aeromonas hydrophila (1X8I) CphA complex with 
Biapenem
227
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APY16311) (data not shown). The Class D carbapenemase AJF40233 (OXA-48-like) displays 
80.35% identity mean (CI 95 ± 34.61) with its clinical Enterobacteria counterparts. Sequences 
pairwise comparison shows 91.00% identity with OXA-48-like (Klebsiella pneumoniae 5FAT 
and K. pneumoniae 4WMC) and 91.70% identity with OXA-244 (K. pneumoniae AGC60012) 
(data not shown). In contrast, for Class B carbapenemases, there are no notable differences 
when comparing environmental carbapenemases with those of clinical Enterobacteria or non-
fermenters of Gram-negative bacilli origin. Particularly, all three NDM-1 carbapenemases of 
environmental sources included in the present study (Table 3) are identical with the car-
bapenemases isolated from K. pneumoniae (3SPU), Enterobacteria, or from the nonfermenter 
Pseudomonas aeruginosa (ALU10771). This is the most obvious illustration of long-term con-
sequences of antibiotics use in livestock farms. Contrary, as it is shown in Table 4, Archaeal 
metallo-hydrolases show low similarities with other Class B carbapenemases.
Multiple sequence alignment of Classes A and D carbapenemases demonstrate that the active-
site residues are very well conserved. Class B carbapenems, which mediate resistance to all beta-
lactamases except aztreonam, are particularly interesting; they are found in bacteria, Archaea, 
and similar proteins, even in eukaryotes. Further, multiple sequence alignment (Figure 10) 
Class Source Organism (accession number) isolation source Beta-lactamase Residues
D ES Escherichia coli (AJA05008)/Halimione portulacoides, 
Portugal
OXA-48 like 215
Citrobacter freundii (AJA05009)/Halimione 
portulacoides, Portugal
OXA-48 like 190
Pantoea eucalypti (AJA05006)/Halimione 
portulacoides, Portugal
OXA-181 173
Uncultured bacterium (AJF40233)/river water, 
Portugal
OXA-48-like 248
E Klebsiella pneumoniae (5FAT) Oxa-48 complex with 
Fpi-1602
243
Klebsiella pneumoniae (4WMC) Oxa-48 complex with 
Avibactam
242
Escherichia coli (3QNC) OXA-10 244
Klebsiella pneumoniae (AGC60012) OXA-244 265
N Pseudomonas aeruginosa (AAQ76282) OXA-50 262
Acinetobacter baumannii (ADB28891) OXA-160 275
Acinetobacter baumannii (4WM9) OXA-24 245
Acinetobacter radioresistens (ACE63186) OXA-23 273
Acinetobacter baylyi (ACH99101.1) OXA-72 275
Table 3. The main characteristics of beta-lactamase sequences.
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Environmental samples Enterobacteria Nonfermenters P-value
Identity%
Mean (CI 95)
Identity%
Mean (CI 95)
Class B
Bacteria
Serratia sp. (ALL98459) 51.07 (±70.37) 40.30 (±42.34) 0.65
A.junii (YP_009062718) 51.07 (±70.37) 40.30 (±42.34) 0.65
A. calcoaceticus 
(YP_009060354)
51.07 (±70.37) 40.30 (±42.34) 0.65
Archaea
S. acidocaldarius 
(WP_011278945)
15.47 (±0.75) 15.56 (±3.04) 0.93
S. acidocaldarius 
(WP_015385554)
14.93 (±1.11) 14.48 (±2.88) 0.69
H. archaeon (KUO42968) 11.00 (±5.81) 13.18 (±2.57) 0.25
A. fulgidus (WP_010877604) 15.27 (±2.67) 15.38 (±1.59) 0.89
V. distributa 
(WP_013336995)
16.50 (±1.51) 16.60 (±2.21) 0.91
Class A
E. asburiae (AIL29239) 54.87 (±17.00) 31.40 (±18.06) 0.02
Uncultured (ALJ52278) 73.03 (±26.33) 40.20 (±26.23) 0.03
Class D
E. coli (AJA05008) 69.85 (±29.32) 28.54 (±2.37) 0.02
C. freundii (AJA05009.1) 67.78 (±25.43) 27.94 (±2.63) 0.01
Peucalypti (AJA05006) 60.93 (±21.63) 25.58 (±2.28) 0.01
Uncultured (AJF40233) 80.35 (±34.61) 32.26 (±3.02) 0.02
CI 95—Confidence Intervals 95%.
Table 4. Pairwise comparison of beta-lactamase sequences of environmental sources with Enterobacteria and non-
fermenters carbapenemases.
highlights the notable differences between Archaea and bacteria. Residues involved in Zn2+ 
ions are very well conserved with the exception of Cys221, which is replaced by Asp in 
Archaea. However, nearby Cys residues were noticed. Since their crystal structures are not 
solved, we can just assume their involvement in metal ion binding.
The observation that Archaea contain different beta-lactamases demonstrates that human 
behavior has not profoundly altered natural environment. Or some microorganism communi-
ties have regulatory mechanisms so flexible that rapidly adapt at new environmental factors. For 
example, Acinetobacter is no longer considered just a free-living organism found in soil, water, 
and skin of human and warm-blooded animals, but an important multidrug-resistant pathogen.
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6. Final remarks
Carbapenems remain a valid option for the treatment of ESBL Enterobacteriaceae pneumo-
nia. Prolonged treatments with beta-lactamine associated with other co-morbidities of the 
patients, rapidly changed the phenotypic pattern of resistance.
Essential oils have, no doubt, beneficial effects, but some providers excessively claim many 
possible effects—from antibacterial activity to neurological benefits—not always consis-
tent with reality. Moreover, nowadays, there exists all sort of mixtures, and we can only 
hope that the ingredients are chosen following logical connections between their activities. 
Herein, these problems were not debated, but it is not a trivial question about the valid-
ity of all plant extracts. Just notice that the only mixture tested (an inhalant) proved no 
antibacterial activity, at least against A. baumannii and E. coli strains. On the other hand, 
tyme-clove association proved to be beneficial in Gram-negative bacilli respiratory infec-
tions. The oregano EO has an excellent antibacterial activity, but its effect is antagonized 
by negril EO. Other plant extracts could be added for their anti-inflammatory effect or just 
for changing the scent [52].
One important question arises from here—what else, apart from widely using of antibiot-
ics, could influence the persistence of antibiotic genes in hospital facilities? Industrial wastes 
could remain for a long period of time in the environment, notably in groundwater [8]. 
Carbapenemases from hospital sources are, no doubt, the major factor in the evolution of 
these enzymes, hospital residues being, definitely, a source of wastewater pollution. Further, 
the carbapenemases produced by natural environmental bacteria and Archaea significantly 
contribute to selection of new mutations. Soil bacterial species greatly influences our life; 
therefore, a genome-scale metabolic network [53] has proved to be a valid approach to evalu-
ate the complex dynamics of soil bacterial species, mostly in geographic areas near huge hos-
pitals with many departments. Also, innate resistance to antibiotics has raised over time a 
growing interest for a rational design of new antibacterial compounds [54].
Figure 10. Multiple sequence alignment of Class B beta-lactamase. The cysteine residues involved in the second Zn2+ 
binding, highly conserved in bacteria, are written in white on black background; the residues noticed in Archaea are 
highlighted - the aspartic acid are underlined and  the cysteine are written on grey background.
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7. Conclusion
Carbapenem-resistant Gram-negative bacilli are one of the leading causes of nosocomial 
pneumonia. They are particularly involved in the outbreaks in ICUs. These strains are very 
often multidrug resistant, putting additional pressure on physicians and clinical micro-
biologists. Bacteriological diagnosis provides essential evidence for carbapenem-resistant 
Gram-negative bacillary pneumonia. From the very beginning, the Gram smear from respi-
ratory specimens shows to be indispensable for an accurate diagnosis. Preventing respira-
tory infections in ICUs is a challenging issue; antibiotic prescription for any kind of acute 
respiratory tract infection does not benefit the patients. Besides, carbapenem-resistant 
bacilli already exist not only in clinical units but also alter environmental microbiota. It is 
time for a different approach in dealing with the antibiotic-resistance issues. An endless 
struggle with microorganisms does not work; these tiny creatures have incredible resources 
to deal with any new chemotherapeutic agent. We do not have the slightest idea of the 
long-term impact of widespread antibiotic use on environmental microorganisms. Careful 
analysis of existing data, like the evidence deposited in public databases, and reconsider-
ing the antibacterial efficiency of natural products, such as EOs, could help at dealing with 
multidrug-resistant organisms.
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